Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| PHARMAMAR | 1 | 2 | -2,11 % | ||
| ALMIRALL | 1 | 1 | -2,64 % | ||
| HBX GROUP INTERNATIONAL PLC | 1 | - | +1,66 % | ||
| EBRO FOODS | - | 3 | -0,66 % | ||
| VIDRALA | - | 3 | -1,52 % | ||
| CIE AUTOMOTIVE | - | 3 | -1,18 % | ||
| GRENERGY RENOVABLES | - | 2 | -3,00 % | ||
| TUBACEX | - | 1 | -2,24 % | ||
| CAF | - | 1 | -2,42 % | ||
| DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION | - | 1 | -2,99 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11:07 | HBX GROUP INTERNATIONAL PLC: The Company shares periodic detail of transactions within the Sharebuy back Programme. | 2 | CNMV | ||
| 08:37 | PHARMA MAR, S.A.: Taiwanese health authorities approve the combination of PharmaMar's Zepzelca (lurbinectedin) and atezolizumab (Tecentriq) as first-line maintenance therapy for advanced small cell lung cancer. | 2 | CNMV | ||
| 08:06 | Almirall's 17th Skin Academy Highlights Scientific Advances in Inflammatory Skin Diseases and Skin Cancer, Patient-Reported Outcomes, and Holistic Care in Medical Dermatology | 164 | Business Wire | Skin Academy brings together leading global experts to advance innovation, collaboration and scientific understanding in medical dermatology, with a focus on improving quality of life for people... ► Artikel lesen | |
| Fr | ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION, S.A.: Proposals for the resolutions to be submitted by the Board of Directors to the Shareholders' General Meeting | 1 | CNMV | ||
| Fr | ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION, S.A.: Call for the Ordinary General Shareholders' Meeting 2026 | 1 | CNMV | ||
| Fr | CIRSA ENTERPRISES, S.A.: Company publishes the text of the call of notice for the Ordinary General Shareholders' Meeting | 1 | CNMV | ||
| Do | PharmaMar looks to accelerate oncology research with AI through collaboration with Globant | 200 | PR Newswire | The new alliance has launched a multi-agent AI framework to support faster, data-driven decisions in cancer research.
Agentic AI system achieves 15x faster insights with over 90% accuracy.... ► Artikel lesen | |
| Do | Almirall celebrates new offices in China to advance innovation in dermatology | 1 | PMLiVE | ||
| Do | Almirall has room to run in terms of meeting targets: Overweight, target price up to €14.50/share | 3 | thecorner.eu | ||
| Mi | Meliã plans to launch hotel investment vehicle with assets valued at between €400 million and €1 billion given difficulty in finding new locations for growth | 1 | thecorner.eu | ||
| Di | SOLARIA ENERGIA Y MEDIOAMBIENTE, S.A.: Solaria reports it has obtained the favourable environmental impact statements (DIA) for the installation of 480 MWh of batteries in 7 PV plants located in Castile-La Mancha (Spain). | 6 | CNMV | ||
| Di | Almirall's Ebglyss (Lebrikizumab) shows positive results in children with moderate to severe atopic dermatitis | 3 | thecorner.eu | ||
| 16.03. | ALMIRALL, S.A.: Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic dermatitis | 1 | CNMV | ||
| 16.03. | Almirall: Lebrikizumab Delivered Significant Skin Clearance and Improved Disease Severity in Children With Moderate-to-severe Atopic Dermatitis | 260 | Business Wire | Almirall announces positive, top-line results from Phase 3 ADorable-1 trial ADorable-1 met co-primary efficacy endpoints, with 63% of paediatric patients achieving meaningful skin improvement... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.